Skip to content

Clinical trials

Phase 2 Muscular Atrophy, Spinal trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Atrophy, Spinal Phase: Phase 2 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20131
20152
20163
20172
20192
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Biogen3
Scholar Rock, Inc.2
University of Utah2
Cytokinetics1
Duke University1
Flex Pharma, Inc.1
NMD Pharma A/S1
University of Oklahoma1
argenx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Atrophy, Spinal18
Amyotrophic Lateral Sclerosis2
Motor Neuron Disease2
Muscle Cramp2
Neuromuscular Diseases2
Neuromuscular Manifestations2
Spinal Muscular Atrophies of Childhood2
Arthrogryposis1
Atrophy1
Cerebral Palsy1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.